Wilkins: Egan's Fundamentals of Respiratory Care, 9th Edition
Chapter 36: Aerosol Drug Therapy
Answer Key to Workbook for Egan’s Fundamentals of Respiratory Care
CHARACTERISTICS OF THERAPEUTIC AEROSOLS
12. Reference: page 803
The ability of aerosols to travel through the air, enter the airways, and deposit in the lung is largely based on particle size.
13. Reference: page 803
14. Reference: page 803
A. deposit in the nose and mouth
B. deposit in the upper and large airways
15. Reference: page 803
A. in the lower airways
B. particles 2 to 5 microns in size.
16. Reference: page 805
Measure the clinical response.
HAZARDS OF AEROSOL THERAPY
17. Reference: page 806
A. Sterilize reusable nebs between patients.
B. Frequently replace nebs with sterile or disinfected units.
C. Rinse nebs with sterile water every 24 hours (not tap water!).
18. Reference: page 806
D. cromolyn sodium
E. ribavirin (and distilled water)
19. Reference: page 806
Administer a bronchodilator prior to giving agents that cause spasm.
20. Reference: page 806
A. Measure peak flow or FEV1.
C. Observe breathing pattern and overall appearance.
D. Communicate with the patient.
21. Reference: page 806
Patients who can’t mobilize secretions; asthmatics may get spasm.
22. Reference: page 806
Reconcentration is when the strength of the drug in the solution increases. This problem is most likely to occur when medications are nebulized for longer than 10 to 15 minutes, such as in continuous nebulization.
AEROSOL DRUG DELIVERY SYSTEMS
23. Reference: page 807
Activating a wasted dose to fill the metering chamber; used for new inhalers and those that have not...